Guidelines for cryoprecipitate transfusion A new document from the Transfusion Medicine Advisory Group describes appropriate use of cryoprecipitate plasma.

The literature shows there is often inappropriate use of blood products, including cryo - precipitate plasma, because of in - adequate education of physicians. Guidelines for cryoprecipitate trans- fusion have been developed by the Transfusion Medicine Advisory Group of British Columbia to educate clini- cians and address transfusion prac- tices in the province. These guide- lines are based on a MEDLINE search and consultation with hema - to pathologists and clinicians. At pre- sent, transfusion of cryoprecipitate is indicated for hypofibrinogen emia/ dysfibrinogenemia, von Willebrand disease, hemophilia A, factor XIII deficiency, and management of bleeding related to thrombolytic therapy. Cryoprecipitate should not be used to prepare fibrin glue or to treat sepsis.